Clinical Trials Logo

Primary Invasive Breast Cancer clinical trials

View clinical trials related to Primary Invasive Breast Cancer.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04016935 Terminated - Clinical trials for Primary Invasive Breast Cancer

EndoPredict® Extended Endocrine Trial (EXET)

Start date: July 2, 2019
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to evaluate the impact of using EndoPredict® clinically to inform treatment decisions for extended endocrine therapy, and the subsequent impact on patient outcomes.

NCT ID: NCT00148720 Terminated - Clinical trials for Stage II Breast Cancer

Capecitabine in Women With Operable Breast Cancer

Start date: September 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out what effects (good and bad) taking capecitabine for 12 weeks before surgery will have on women with breast cancer.